← Leaderboards
Mary Ann McLane
University Of Delaware
$925,239
Attributed
$925,239
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $215.2K · FY2005–11$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$925,239 · 3
By mechanism
R01$705,138 · 1
R15$150,000 · 1
P20$70,101 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Delaware
Same institution · by research overlap
- Ulhas P Naik$17,016,768
- Roberta Fishman Colman$8,331,851
- Freda Patterson$3,804,023
- John Hundley Slater$1,966,089
Others in their field
Top investigators on “Fibronectins”
- Martin A. Schwartz · Yale University$11,822,401
- Timothy A Springer · Boston Children'S Hospital$11,405,849
- Richard F Loeser · Rush University Medical Center$9,001,150
- Sophie Astrof · Rutgers Biomedical And Health Sciences$8,825,404
- Jean E Schwarzbauer · Princeton University$8,747,637
- Donald B Arnold · University Of Southern California$7,985,852
Research focus
FibronectinsMelanomaCollagenVitronectinCell LineDisease /Disorder ModelMetastasisNeoplasm /Cancer PharmacologyIntegrinsLamininLaboratory MouseCrosslinkReptile PoisonRecombinant ProteinsProtein SequencePeptidesPeptide StructureIntermolecular InteractionClinical ResearchHuman SubjectImmunocytochemistryGlutathione TransferaseMutantCell Physiology
Grant awards (5)
DIRECT INTERACTION OF ERISTOSTATIN WITH MELANOMA CELL SURFACE MOLECULES$70,101
P20 · FY2011 · RR · contact PI
Melanoma Metastasis Inhibition by Eristostatin$215,175
R01 · FY2005 · CA
Melanoma Metastasis Inhibition by Eristostatin$251,038
R01 · FY2004 · CA
Melanoma Metastasis Inhibition by Eristostatin$238,925
R01 · FY2003 · CA
Inhibition of Melanoma metastasis by Eristostatin$150,000
R15 · FY2001 · CA